Avicanna Inc: RichTV in Discussion With the CEO Aras Azaidan
The biopharmaceutical sector has seen plenty of action over the course of the past months and many such stocks have managed to record significant gains due to a variety of reasons. Hence, it is no surprise that there are now many investors who are actively looking for such stocks. However, one needs to be diligent with regards to research and go by only reliable sources of information. In that regard, the YouTube channel RichTV Live could be worth following.
Major Details
It has proven to be quite reliable as far as investment-related information is concerned and a video this past Friday showcased the biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN). More importantly, the Chief Executive Officer of the company Aras Azaidan joined the RichTV analyst for a chat as well.
There was also a significant development with regards to Avicanna that might have brought the company to the attention of investors on Friday. The company is involved in developing, manufacturing, and marketing of CBD based products.
This past Friday Avicanna announced that entered into an agreement with Harrington Wellness Inc with regards to royalty agreement and intellectual property licensing. The agreement in question relates to commercializing a product line of CBD items that are targeted at athletes. It goes without saying that the product line could end up being highly lucrative and hence, it is a key development for Avicanna.
The company’s CEO Azaidan started the chat by saying that he is the founding CEO of Avicanna. There were two other co-founders at the company but they eventually left the company. However, it is interesting to note that his background lies in biotech but he wanted to create a line of standardized medicines that are made out of CBD. That was the rationale behind setting up the company.
It is a well-known fact that CBD products have become highly popular among a diverse section of people over the course of the past years and it is probably a matter of time before those products become even more popular. Avicanna is clearly trying to diversify its range of products and the latest agreement is an indication that the company is moving in that direction.
Over the course of the past months, Rich Tv Live has emerged as one of the most interesting YouTube channels for investors. The channel publishes new videos every day and one of the more important ... [Read]
Once again, Rich has returned with a list of 10 best stocks to buy or watch in the coming month. His last list featured some pretty big winners, so congratulations to everyone who made out ... [Read]
Last December, Rich named Else Nutrition Holdings Inc. (TSXV:BABY) (OTCPK:BABYF) one of his top picks for 2020. The adolescent and adult food and nutrition company had already gained approximately 50% since Rich first covered them ... [Read]
One of Rich’s biggest stock picks for May is Geomega Resources Inc (TSXV:GMA) (OTCPK:GOMRF). Based in Boucherville and St-Bruno, Canada, Geomega has developed a proprietary, environmentally-friendly “ISR Technology.” This tech recycles rare earth elements, with a specific ... [Read]
Rich first profiled Inovio Pharmaceuticals Inc. (NASDAQ:INO) just before it exploded in early March. The pharma stock went from $4.39 to $14.09 over the course of just one week, though it didn’t stay there for ... [Read]
Continuing his coverage of companies making big moves in addressing COVID-19, Rich is turning his attention today towards Global Care Capital Corp. (CSE:HLTH) (OTC:RSCZF). This stock has been on a major bull run lately, so let’s ... [Read]
Since the COVID-19 crisis began, healthcare stocks around the world have generally been soaring. That’s why today, Rich is interviewing the CEO of a promising healthcare stock, Allstar Health Brands Inc (OTCPK:ALST). AllStar Health Brands ... [Read]
Yesterday, Rich profiled one of the biggest COVID-19 winners, Aytu BioScience Inc (NASDAQ:AYTU). While that remains a hot stock as the markets opened today, Rich has even more picks to share with his community members. So ... [Read]
There’s been no shortage of biotech stocks to cover these past few weeks. Rich has extensively covered the companies currently working on a treatment, vaccine, or cure for COVID-19. Today, he profiles Aytu BioScience Inc ... [Read]
Risks and Disclosure:
Information provided in this correspondence is intended solely for informational purposes and is obtained from sources believed to be reliable. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained on this website is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions made or suggested and the actual results.
All statements and opinions expressed are the opinions of the author and not of Richtvlive.com or its officers. The author is wholly responsible for the validity of all statements. Richtvlive.com was not involved in any aspect of the article preparation. The author was not paid by Bitrex Inc for this article. The author did not pay Richtvlive.com to publish or syndicate this article.
This article does not constitute as investment advice. Each reader is encouraged to consult with his or her individual financial advisor; any and all actions taken by a reader as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Richtvlive.com's terms of use and full legal disclaimer. This article is in no way a solicitation for investment. Richtvlive.com does not render general or specific investment advice. Any information on Richtvlive.com should not be considered a recommendation to buy or sell any security. Richtvlive.com does not endorse or recommend the business, products, services or securities of any company mentioned on Richtvlive.com.
Futures, stocks and options trading involves substantial risk of loss and is not suitable for every investor. The valuation of futures, stocks, and options may fluctuate, and, as a result, clients may lose more than their original investment and possibly their entire investment. Any content on this website should not be relied upon as advice or construed as providing recommendations of any kind. It is your responsibility to confirm and decide which trades to make. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
Please see our full disclaimer here for additional details before making any investment decisions.